Lumature Wealth Partners’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
$248K Sell
2,820
-22
-0.8% -$1.89K 0.15% 136
2023
Q1
$229K Buy
2,842
+165
+6% +$13.4K 0.13% 143
2022
Q4
$208K Sell
2,677
-87
-3% -$7.05K 0.12% 147
2022
Q3
$223K Buy
2,764
+69
+3% +$6.2K 0.12% 137
2022
Q2
$242K Sell
2,695
-768
-22% -$77.8K 0.11% 140
2022
Q1
$384K Buy
3,463
+2,289
+195% +$242K 0.15% 104
2021
Q4
$121K Sell
1,174
-61
-5% -$7.06K 0.05% 165
2021
Q3
$155K Sell
1,235
-128
-9% -$16.6K 0.06% 152
2021
Q2
$169K Sell
1,363
-135
-9% -$16.9K 0.07% 151
2021
Q1
$177K Sell
1,498
-4,373
-74% -$513K 0.09% 126
2020
Q4
$688K Buy
+5,871
New +$646K 0.65% 37

Other funds holding MDT

Lumature Wealth Partners's MDT Position: Q2 2023 in Review

Lumature Wealth Partners reduced its Medtronic (MDT) stake by 0.77% in Q2 2023, selling an estimated $1.89K and leaving 2,820 shares worth $248K. The position accounts for 0.15% of the portfolio, ranked #136.

Lumature Wealth Partners first reported a position in MDT in Q4 2020 and has held it in 11 quarters since. The position peaked at $688K in Q4 2020. 2,057 funds tracked by Wall St. Rank hold MDT as of Q2 2023.

  • Lumature Wealth Partners held 2,820 shares of Medtronic worth $248K as of Q2 2023.
  • Lumature Wealth Partners sold 22 Medtronic shares in Q2 2023, an estimated $1.89K.
  • Medtronic made up 0.15% of Lumature Wealth Partners's portfolio in Q2 2023, its #136 holding.
  • Lumature Wealth Partners first reported a position in Medtronic in Q4 2020 and has held it in 11 quarters since.
  • Lumature Wealth Partners's Medtronic position peaked at $688K in Q4 2020.
  • 2,057 funds tracked by Wall St. Rank held Medtronic as of Q2 2023.

Based on Lumature Wealth Partners's 13F filing for Q2 2023, filed 14 Aug 2023.